SVP, CFO & Sec of Alexza Pharmaceuticals Inc. (ALXA, Financial) August J Moretti sells 14,000 shares of ALXA on 12/18/2009 at an average price of $2.23 a share.
Alexza Pharmaceuticals is an emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. Alexza Pharmaceuticals Inc. has a market cap of $105.81 million; its shares were traded at around $2.05 with and P/S ratio of 217.73.
Alexza Pharmaceuticals is an emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. Alexza Pharmaceuticals Inc. has a market cap of $105.81 million; its shares were traded at around $2.05 with and P/S ratio of 217.73.
CEO Recent Trades:
- Buy:: Pres & CEO Thomas Braxton King bought 64,655 shares of ALXA stock on 10/05/2009 at the average price of 2.32, the price of the stock has decreased by 11.64% since.
- Sell:: Pres & CEO Thomas Braxton King sold 44,994 shares of ALXA stock on 12/18/2009 at the average price of 2.23, the price of the stock has decreased by 8.07% since.
CFO Recent Trades:
- Sell:: SVP, CFO & Sec August J Moretti sold 14,009 shares of ALXA stock on 12/18/2009 at the average price of 2.23, the price of the stock has decreased by 8.07% since.
Directors and Officers Recent Trades:
- Sell:: SVP, Research & Development James V Cassella sold 24,424 shares of ALXA stock on 12/18/2009 at the average price of 2.23, the price of the stock has decreased by 8.07% since.
- Sell:: SVP, Operations & Quality Michael J Simms sold 9,770 shares of ALXA stock on 12/18/2009 at the average price of 2.23, the price of the stock has decreased by 8.07% since.
